Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Circulating tumour cells

SABCS 2008

10 - 14 Dec 2008

Published: 12 Jan 2009

Views: 18572

Rating:

Save

Professor Klaus Pantel, University Medical Center Hamburg-Eppendorf

Detection of disseminating tumour cells in the blood at a single cell level to predict and prevent metastatic relapse in breast cancer patients

Related Videos

Genetic profiling identifies patients who can omit radiation therapy after...

Prof Per Karlsson - Sahlgrenska Comprehensive Cancer Centre, Gothenburg, Sweden

Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery ( Prof Per Karlsson - Sahlgrenska Comprehensive Cancer Centre, Gothenburg, Sweden )

Breast cancer in elderly patients: a clinicopathological review of a Nigerian...

Dr Funmilola Wuraola - Obafemi Awolowo University Teaching Hospital, Ilé-Ifẹ̀...

Breast cancer in elderly patients: a clinicopathological review of a Nigerian database ( Dr Funmilola Wuraola - Obafemi Awolowo University Teaching Hospital, Ilé-Ifẹ̀, Nigeria )

Addition of platinum to standard neoadjuvant chemotherapy improves EFS in...

Dr Sudeep Gupta - Tata Memorial Centre, Mumbai, India

Addition of platinum to standard neoadjuvant chemotherapy improves EFS in patients with TNMBC ( Dr Sudeep Gupta - Tata Memorial Centre, Mumbai, India )

Treatment decision guided by CTC count may improve long-term outcomes for mBC

Prof Jean-Yves Pierga - Institut Curie, Paris, France

Treatment decision guided by CTC count may improve long-term outcomes for mBC ( Prof Jean-Yves Pierga - Institut Curie, Paris, France )

Addressing women’s cancers: an economic evaluation of breast and cervical...

Dr Mary Nyangasi - Head of the National Cancer Control Programme, Nairobi, Kenya

Addressing women’s cancers: an economic evaluation of breast and cervical cancer interventions in Kenya ( Dr Mary Nyangasi - Head of the National Cancer Control Programme, Nairobi, Kenya )

Long-term breast cancer risk after benign breast disease in population-based...

Dr Marta Roman - Hospital del Mar Medical Research Institute, Barcelona, Spain

Long-term breast cancer risk after benign breast disease in population-based screening ( Dr Marta Roman - Hospital del Mar Medical Research Institute, Barcelona, Spain )

Individualised breast cancer risk assessment model for BreastScreen Norway

Dr Javier Louro - Hospital del Mar Medical Research Institute, Barcelona, Spain.

Individualised breast cancer risk assessment model for BreastScreen Norway ( Dr Javier Louro - Hospital del Mar Medical Research Institute, Barcelona, Spain. )

HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan

Prof Naoto Ueno - The University of Texas MD Anderson Cancer Center, Houston...

HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan ( Prof Naoto Ueno - The University of Texas MD Anderson Cancer Center, Houston, USA )

Extended adjuvant AI not advised for HPBC after 5+ yrs of sequential endocrine...

Dr Vivianne Tjan-Heijnen - Maastricht University Medical Center, Maastricht...

Extended adjuvant AI not advised for HPBC after 5+ yrs of sequential endocrine therapy ( Dr Vivianne Tjan-Heijnen - Maastricht University Medical Center, Maastricht, Netherlands )

More from ecancer